Frederick Pediatric Associates P.A.

Frederick Pediatric Associates P.A. was paid $7.64M by Medicaid between Jan 2018 and Dec 2024, across 67 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 31% of everything it billed.

33Billing provider infoFREDERICK PEDIATRIC ASSOCIATES P.A.
FREDERICK, MD 21702

33aNPI1538146717assigned 12/28/2005

33bProvider typePediatrics Physician

28Total paid$7.64M

24GClaims161,421

24DCodes billed67

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Pediatrics Physician providers in Maryland

Rank by total paid#12 of 306

Median peer was paid$206K

This provider vs. median37×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	778	$23K
2019	484	$18K
2020	23,980	$1.05M
2021	26,550	$1.20M
2022	36,806	$1.77M
2023	36,515	$1.83M
2024incomplete	36,308	$1.74M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	31%	28,282	25,217	$2.40M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	20%	12,265	11,400	$1.52M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	10%	7,164	6,987	$773K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	8.8%	6,686	6,401	$673K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	6.4%	4,503	4,391	$485K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	3.6%	2,329	2,259	$271K
90686		1.7%	5,664	5,419	$127K
96110	Developmental screening, with scoring and documentation, per standardized instrument	1.6%	11,664	11,370	$122K
90648		1.5%	5,145	4,960	$115K
99381		1.3%	945	891	$103K
90671		1.2%	1,761	1,686	$91K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	1.1%	7,144	6,509	$86K

55 more codes

90723		1.1%	3,663	$82K
92551		<1%	8,099	$76K
90670		<1%	3,289	$75K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	1,316	$56K
87428		<1%	1,854	$54K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	2,132	$51K
90633		<1%	2,083	$47K
90681		<1%	2,052	$46K
D1206	Topical application of fluoride varnish	<1%	2,476	$44K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	1,668	$28K
90716		<1%	990	$23K
90651		<1%	965	$23K
90734		<1%	926	$21K
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	1,291	$21K
90700		<1%	912	$21K
90707		<1%	900	$20K
83655		<1%	1,789	$20K
90710		<1%	816	$19K
90656		<1%	795	$18K
99173		<1%	7,160	$18K
90696		<1%	773	$17K
94760		<1%	9,728	$16K
99050		<1%	765	$10K
90715		<1%	430	$10K
96127		<1%	1,593	$8K
90381		<1%	66	$6K
87807		<1%	497	$5K
99383		<1%	44	$5K
99460		<1%	52	$5K
99244	Office or other outpatient consultation, moderate to high complexity	<1%	27	$5K
85018		<1%	1,918	$4K
99238	Hospital discharge day management, 30 minutes or less	<1%	54	$4K
90620		<1%	101	$3K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	237	$2K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	110	$2K
99384		<1%	12	$2K
90380		<1%	29	$2K
0071A		<1%	42	$2K
0072A		<1%	35	$1K
G8417	Bmi is documented above normal parameters and a follow-up plan is documented	<1%	76	$700.00
99051		<1%	55	$669.46
81003		<1%	285	$568.98
A7003	Administration set, with small volume nonfiltered pneumatic nebulizer, disposable	<1%	223	$407.13
99000		<1%	4,745	$333.01
90660		<1%	12	$279.36
94664		<1%	13	$182.00
94761		<1%	82	$150.93
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	134	$140.51
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	224	$90.04
G2012	Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion	<1%	67	$50.32
36416		<1%	141	$30.00
36415	Collection of venous blood by venipuncture	<1%	12	$18.00
91308		0%	17	$0.00
91307		0%	82	$0.00
INVCD		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialNATHAN, RADHA (PRESIDENT)